(11-050) Renal Risk or Reward: A Comparative Study of Sacubitril/Valsartan versus Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in Acute Kidney Injury Development
Wednesday, December 10, 2025
12:30 PM - 1:30 PM
Location: Bayside A, Level 1
Residency Program: Trinity Health Ann Arbor Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Michigan
